EG22775A - Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof - Google Patents

Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof

Info

Publication number
EG22775A
EG22775A EG20001282A EG20001282A EG22775A EG 22775 A EG22775 A EG 22775A EG 20001282 A EG20001282 A EG 20001282A EG 20001282 A EG20001282 A EG 20001282A EG 22775 A EG22775 A EG 22775A
Authority
EG
Egypt
Prior art keywords
pyridylsulphonyl
pyrazolo
pyrimidin
intermediates
ones
Prior art date
Application number
EG20001282A
Other languages
English (en)
Inventor
Keith M Devries
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924042.6A external-priority patent/GB9924042D0/en
Priority claimed from GB0018667A external-priority patent/GB0018667D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG22775A publication Critical patent/EG22775A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
EG20001282A 1999-10-11 2000-10-09 Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof EG22775A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924042.6A GB9924042D0 (en) 1999-10-11 1999-10-11 Process for thr preparation of pyrazolo[4,3-D]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
GB0018667A GB0018667D0 (en) 2000-07-28 2000-07-28 Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
EG22775A true EG22775A (en) 2003-08-31

Family

ID=26244761

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20001282A EG22775A (en) 1999-10-11 2000-10-09 Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof

Country Status (39)

Country Link
EP (1) EP1092720B1 (cg-RX-API-DMAC7.html)
JP (1) JP2001114783A (cg-RX-API-DMAC7.html)
KR (1) KR100395718B1 (cg-RX-API-DMAC7.html)
CN (1) CN1292379A (cg-RX-API-DMAC7.html)
AR (1) AR029767A1 (cg-RX-API-DMAC7.html)
AT (1) ATE286899T1 (cg-RX-API-DMAC7.html)
AU (1) AU6543600A (cg-RX-API-DMAC7.html)
BG (1) BG104840A (cg-RX-API-DMAC7.html)
BR (1) BR0004787A (cg-RX-API-DMAC7.html)
CA (1) CA2322995A1 (cg-RX-API-DMAC7.html)
CO (1) CO5251476A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20003754A3 (cg-RX-API-DMAC7.html)
DE (1) DE60017330D1 (cg-RX-API-DMAC7.html)
DZ (1) DZ3096A1 (cg-RX-API-DMAC7.html)
EA (1) EA003145B1 (cg-RX-API-DMAC7.html)
EE (1) EE200000537A (cg-RX-API-DMAC7.html)
EG (1) EG22775A (cg-RX-API-DMAC7.html)
GT (1) GT200000169A (cg-RX-API-DMAC7.html)
HR (1) HRP20000674A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0003979A3 (cg-RX-API-DMAC7.html)
ID (1) ID27539A (cg-RX-API-DMAC7.html)
IL (1) IL138913A0 (cg-RX-API-DMAC7.html)
IN (1) IN190477B (cg-RX-API-DMAC7.html)
IS (1) IS5654A (cg-RX-API-DMAC7.html)
MA (1) MA25867A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA00009936A (cg-RX-API-DMAC7.html)
NO (1) NO316072B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ507431A (cg-RX-API-DMAC7.html)
OA (1) OA11495A (cg-RX-API-DMAC7.html)
PA (1) PA8504601A1 (cg-RX-API-DMAC7.html)
PE (1) PE20010682A1 (cg-RX-API-DMAC7.html)
PL (1) PL343140A1 (cg-RX-API-DMAC7.html)
SG (1) SG97950A1 (cg-RX-API-DMAC7.html)
SK (1) SK15052000A3 (cg-RX-API-DMAC7.html)
SV (1) SV2002000194A (cg-RX-API-DMAC7.html)
TN (1) TNSN00195A1 (cg-RX-API-DMAC7.html)
TR (1) TR200002959A2 (cg-RX-API-DMAC7.html)
UY (1) UY26388A1 (cg-RX-API-DMAC7.html)
YU (1) YU59100A (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
US6809200B2 (en) * 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2006219373A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
JP5254029B2 (ja) * 2005-11-16 2013-08-07 エフ．ホフマン−ラ ロシュ アーゲー Ｔｈｏｃの新規製造方法
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
AU2012221828C1 (en) * 2011-02-23 2015-10-01 Pfizer Inc. Imidazo[5,1-f][1,2,4]triazines for treatment of neurological disorders
CA3044164A1 (en) * 2016-11-21 2018-05-24 Adama Agan Ltd. Process for preparing methoxy methyl pyridine dicarboxylate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ338075A (en) * 1997-04-25 2000-10-27 Pfizer Ltd Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PED5) for the treatment of sexual dysfunction
ATE299503T1 (de) * 1998-04-20 2005-07-15 Pfizer Pyridin-3-carbonsäurederivate und ihre verwendung als zwischenprodukte
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera

Also Published As

Publication number Publication date
OA11495A (en) 2004-05-05
NZ507431A (en) 2002-09-27
IS5654A (is) 2001-04-12
SG97950A1 (en) 2003-08-20
EP1092720A3 (en) 2001-09-19
ATE286899T1 (de) 2005-01-15
CA2322995A1 (en) 2001-04-11
ID27539A (id) 2001-04-12
GT200000169A (es) 2002-04-03
MXPA00009936A (es) 2002-10-23
HU0003979D0 (en) 2000-12-28
EA200000924A2 (ru) 2001-04-23
TNSN00195A1 (fr) 2005-11-10
EE200000537A (et) 2001-06-15
BG104840A (bg) 2001-10-31
PA8504601A1 (es) 2002-02-21
KR100395718B1 (ko) 2003-08-25
PE20010682A1 (es) 2001-07-04
CN1292379A (zh) 2001-04-25
DE60017330D1 (de) 2005-02-17
IN190477B (cg-RX-API-DMAC7.html) 2003-08-02
HRP20000674A2 (en) 2001-08-31
HUP0003979A2 (hu) 2001-12-28
JP2001114783A (ja) 2001-04-24
NO20005104D0 (no) 2000-10-10
NO20005104L (no) 2001-04-17
HUP0003979A3 (en) 2002-03-28
SK15052000A3 (sk) 2003-01-09
TR200002959A2 (tr) 2001-07-23
EP1092720B1 (en) 2005-01-12
EA200000924A3 (ru) 2001-06-25
AR029767A1 (es) 2003-07-16
DZ3096A1 (fr) 2004-06-20
BR0004787A (pt) 2001-05-22
YU59100A (sh) 2003-10-31
UY26388A1 (es) 2001-05-31
AU6543600A (en) 2001-04-12
KR20010050935A (ko) 2001-06-25
IL138913A0 (en) 2001-11-25
CO5251476A1 (es) 2003-02-28
SV2002000194A (es) 2002-01-23
CZ20003754A3 (cs) 2002-06-12
EP1092720A2 (en) 2001-04-18
EA003145B1 (ru) 2003-02-27
NO316072B1 (no) 2003-12-08
MA25867A1 (fr) 2003-10-01
PL343140A1 (en) 2001-04-23

Similar Documents

Publication Publication Date Title
IL198040A0 (en) Intermediates for the preparation of triazolo (4,5-d) pyrimidine compounds
HUP0302345A3 (en) Novel triazolo pyrimidine compounds, their intermediates and process for their preparation
PL342430A1 (en) Novel compounds of triazolo[4,5-d]pyrimidine
PT1674456E (pt) Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas
IL128505A0 (en) Process for the preparation of pyrimidine compounds
AU5491699A (en) Process for the preparation of pyrrolo(2,3-d)pyrimidines
HRP990318B1 (en) PROCESS FOR PREPARATION OF PYRAZOLO/4,3-d/PYRIMIDIN-7-ONES AND INTERMEDIATES THEREOF
IL144516A0 (en) PROCESS FOR THE PREPARATION OF PYRAZOLO [4,3-d] PYRIMIDIN-7-ONE COMPOUNDS AND INTERMEDIATES THEREOF
AU9121001A (en) Process for the preparation of 2-alkoxy-6-trifluoromethyl-N-((1,2,4)triazolo(1,5-c) pyrimidin-2-yl)benzenesulfonamides
EG22775A (en) Process for the preparation of pyrazolo (f,5-d) pyrimidin 7 ones-3-pyridylsulphonyl compounds and intermediates thereof
HUP0301399A3 (en) Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine
HUP0200830A3 (en) Process for the preparation of substituted pyrimidines
PL355637A1 (en) Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition
IL134144A0 (en) Process for the preparation of organic azides
GB0110251D0 (en) Process for the preparation of pyrazolo[4,4-d]Pyrimidin-7-one compounds and intermediates thereof
ZA200005581B (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
ZA200106161B (en) Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof.
GB0107526D0 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-one compounds and intermediates thereof
IL120560A0 (en) Process for the preparation of pyrimidinone compounds and intermediates produced thereby
GB0018667D0 (en) Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
AU1821900A (en) Process for the preparation of quinazolinones
HK1032589A (en) Novel triazolo(4,5-d)pyrimidine compounds
SI1200414T1 (en) Process for the preparation of substituted pyrimidines
AU2001291210A1 (en) Process for the preparation of 2-alkoxy-6-trifluoromethyl-n-((1,2,4)triazolo(1,5-c)pyrimidin-2-yl)benzenesulfonamides
HK1022632A (en) The use of 1, 2, 4-triazolo(1, 5,-c)pyrimidine heterocyclic analogues for the preparation of medicaments useful for the treatment of cerebrovascular disturbances